Publications by authors named "R Gerbutavicius"
Evaluation of Subclinical Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Hematopoietic Stem Cell Transplantation: An Echocardiography Study.
Cancers (Basel)
November 2024
Article Synopsis
- Hematopoietic stem cell transplantation (HSCT) is a treatment for blood cancers that can potentially cure patients, but it is linked to increasing cases of cardiac dysfunction over time.
- A study of 55 HSCT patients found that 27.3% developed asymptomatic cardiac dysfunction one year post-transplant, with some classified as having moderate or mild dysfunction.
- Key factors associated with increased risk of cardiac dysfunction included previous use of anthracyclines and undergoing the BEAM chemotherapy regimen as part of the conditioning process before HSCT.
Hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of cardiovascular diseases. In our study, we aimed to find subclinical changes in myocardial tissue after HSCT with the help of cardiovascular magnetic resonance (CMR) tissue imaging techniques. The data of 44 patients undergoing autologous and allogeneic HSCT in the Hospital of Lithuanian University of Health Sciences Kaunas Clinics from October 2021 to February 2023 were analyzed.
View Article and Find Full Text PDFBackground: Cataract surgeries are among the most performed surgeries worldwide. A thorough patient education is essential to inform patients about the perioperative process and postoperative target results concerning the intraocular lens and objectives for visual outcomes. However, addressing all relevant aspects and questions is time-consuming.
View Article and Find Full Text PDFThe hematopoietic stem cell transplantation (HSCT) process is known to cause cardiac toxicity of different grades. In this paper, we aimed to evaluate the impact of mobilization procedure of hematopoietic stem cells for autologous HSCT process for left and right ventricle sizes and functions. The data of 47 patients undergoing autologous HSCT were analyzed.
View Article and Find Full Text PDFThe morbidity and mortality of -negative myeloproliferative neoplasia (MPN) patients is highly dependent on thrombosis that may be affected by antiphospholipid antibodies (aPLA) and anticoagulant. Our aim was to evaluate the association of the aPLA together with platelet receptor glycoprotein (GP) Ia/IIa c.807C>T CT/TT genotypes and thrombotic complications in patients with MPNs.
View Article and Find Full Text PDF